Skip to content

Neuroregulatory Intervention for Visuospatial Learning Deficits in First-Periord Schizophrenia

Neuroregulatory Intervention for Visuospatial Learning Deficits in First-Periord Schizophrenia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117867
Enrollment
Unknown
Registered
2026-01-29
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

First-episode schizophrenia, in the active phase

Interventions

TMS sham group:TMS sham stimulation
TMS group:Transcranial magnetic stimulation therapy

Sponsors

Nantong Fourth People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1.Aged 14-45 years; 2. First hospitalization, with a disease duration of =6 years, IQ >=70 (Wechsler background); 4. MCCB score for the visuospatial factor <=6 points, T <=26 points; 5. Able to cooperate to complete the assessment; 6. Meets the diagnostic criteria for schizophrenia according to the International Classification of Diseases, Tenth Revision (ICD-10).

Exclusion criteria

Exclusion criteria: 1.Correction of vision <0.8; 2.contraindications for TMS treatment; 3.history of head trauma leading to coma; 4.drug or alcohol dependence; 5.pregnant or lactating women; 6.individuals with high suicide risk;

Design outcomes

Primary

MeasureTime frame
Cytokines;Negative and Positive Symptoms Scale;Complement;MCCB Chinese Version of the Cognitive Function Assessment Scale;

Secondary

MeasureTime frame
Hamilton Depression Scale,HAMD;Hamilton Anxiety Scale,HAMA;

Countries

China

Contacts

Public ContactChen Xing

Nantong Fourth People’s Hospital

cx109003143@qq.com+86 513 85606981

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026